{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:03:43Z","timestamp":1780333423758,"version":"3.54.1"},"reference-count":32,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"DOI":"10.61622\/rbgo\/2026rbgo16","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:29:54Z","timestamp":1780331394000},"source":"Crossref","is-referenced-by-count":0,"title":["Insights about use of p57 in differentiation between complete and partial hydatidiform mole: a scoping review"],"prefix":"10.61622","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2135-9314","authenticated-orcid":false,"given":"Isabelle Sasso","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1676-7826","authenticated-orcid":false,"given":"Sheldon Rodrigo","family":"Botogoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1234-8093","authenticated-orcid":false,"given":"Renato","family":"Nisihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"issue":"3","key":"key20260601162945_B1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2021.10.003","article-title":"Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: a Society of Gynecologic Oncology evidenced-based review and recommendation","volume":"163","author":"Horowitz","year":"2021","unstructured":"1 Horowitz NS, Eskander RN, Adelman MR, Burke W. Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: a Society of Gynecologic Oncology evidenced-based review and recommendation. Gynecol Oncol. 2021;163(3):605-13. doi: 10.1016\/j.ygyno.2021.10.003","journal-title":"Gynecol Oncol"},{"issue":"6","key":"key20260601162945_B2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.hoc.2024.07.003","article-title":"Epidemiology of gestational trophoblastic disease","volume":"38","author":"Joneborg","year":"2024","unstructured":"2 Joneborg U. Epidemiology of gestational trophoblastic disease. Hematol Oncol Clin North Am. 2024;38(6):1199-210. doi: 10.1016\/j.hoc.2024.07.003","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20260601162945_B3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bpobgyn.2021.01.004","article-title":"Genetics of gestational trophoblastic disease","volume":"74","author":"Fisher","year":"2021","unstructured":"3 Fisher RA, Maher GJ. Genetics of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2021;74:29-41. doi: 10.1016\/j.bpobgyn.2021.01.004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"Suppl 1","key":"key20260601162945_B4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155","author":"Ngan","year":"2021","unstructured":"4 Ngan HY, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021;155 (Suppl 1):86-93. doi: 10.1002\/ijgo.13877","journal-title":"Int J Gynaecol Obstet"},{"key":"key20260601162945_B5","volume-title":"Linha de cuidados para doen\u00e7a trofobl\u00e1stica gestacional","author":"Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade. Departamento de A\u00e7\u00f5es Program\u00e1ticas e Estrat\u00e9gicas","year":"2022","unstructured":"5 Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade. Departamento de A\u00e7\u00f5es Program\u00e1ticas e Estrat\u00e9gicas. Linha de cuidados para doen\u00e7a trofobl\u00e1stica gestacional. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2022 [citado 2025 Ago 22]. Dispon\u00edvel em: https:\/\/portaldeboaspraticas.iff.fiocruz.br\/wp-content\/uploads\/2022\/01\/linha_cuidado_trofoblasticas.pdf"},{"issue":"4","key":"key20260601162945_B6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5455\/medarh.2017.71.256-260","article-title":"Challenges in the routine praxis diagnosis of hydatidiform mole: a tertiary health center experience","volume":"71","author":"Lelic","year":"2017","unstructured":"6 Lelic M, Fatusic Z, Iljazovic E, Ramic S, Markovic S, Alicelebic S. Challenges in the routine praxis diagnosis of hydatidiform mole: a tertiary health center experience. Med Arch. 2017;71(4):256-60. doi: 10.5455\/medarh.2017.71.256-260","journal-title":"Med Arch"},{"issue":"10","key":"key20260601162945_B7","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/1471-0528.15289","article-title":"Accuracy of p57 KIP2 compared with genotyping to diagnose complete hydatidiform mole: a systematic review and meta-analysis","volume":"125","author":"Madi","year":"2018","unstructured":"7 Madi JM, Braga A, Paganella MP, Litvin IE, Wendland EM. Accuracy of p57 KIP2 compared with genotyping to diagnose complete hydatidiform mole: a systematic review and meta-analysis. BJOG. 2018;125(10):1226-33. doi: 10.1111\/1471-0528.15289","journal-title":"BJOG"},{"issue":"6","key":"key20260601162945_B8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/ijgc-2021-003312","article-title":"Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry","volume":"32","author":"Schoenen","year":"2022","unstructured":"8 Schoenen S, Delbecque K, Van Rompuy AS, Marbaix E, Noel JC, Delvenne P, et al. Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry. Int J Gynecol Cancer. 2022;32(6):740-5. doi: 10.1136\/ijgc-2021-003312","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"key20260601162945_B9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/PAS.0b013e318191f309","article-title":"Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach","volume":"33","author":"McConnell","year":"2009","unstructured":"9 McConnell TG, Murphy KM, Hafez M, Vang R, Ronnett BM. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol. 2009;33(6):805-17. doi: 10.1097\/PAS.0b013e318191f309","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"key20260601162945_B10","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5858\/arpa.2018-0226-RA","article-title":"Hydatidiform moles: ancillary techniques to refine diagnosis","volume":"142","author":"Ronnett","year":"2018","unstructured":"10 Ronnett BM. Hydatidiform moles: ancillary techniques to refine diagnosis. Arch Pathol Lab Med. 2018;142(12):1485-502. doi: 10.5858\/arpa.2018-0226-RA","journal-title":"Arch Pathol Lab Med"},{"key":"key20260601162945_B11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-pathol-052016-100237","article-title":"Hydatidiform moles: genetic basis and precision diagnosis","volume":"12","author":"Hui","year":"2017","unstructured":"11 Hui P, Buza N, Murphy KM, Ronnett BM. Hydatidiform moles: genetic basis and precision diagnosis. Annu Rev Pathol. 2017;12:449-85. doi: 10.1146\/annurev-pathol-052016-100237","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"key20260601162945_B12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAS.0000000000001749","article-title":"Loss of p57 expression in conceptions other than complete hydatidiform mole: a case series with emphasis on the etiology, genetics, and clinical significance","volume":"46","author":"Xing","year":"2022","unstructured":"12 Xing D, Miller K, Beierl K, Ronnett BM. Loss of p57 expression in conceptions other than complete hydatidiform mole: a case series with emphasis on the etiology, genetics, and clinical significance. Am J Surg Pathol. 2022;46(1):18-32. doi: 10.1097\/PAS.0000000000001749","journal-title":"Am J Surg Pathol"},{"key":"key20260601162945_B13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2020.04.011","article-title":"p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases","volume":"101","author":"Gaillot-Durand","year":"2020","unstructured":"13 Gaillot-Durand L, Patrier S, Aziza J, Devisme L, Riera AC, Marcorelles P, et al. p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases. Hum Pathol. 2020;101:18-30. doi: 10.1016\/j.humpath.2020.04.011","journal-title":"Hum Pathol"},{"issue":"3","key":"key20260601162945_B14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","unstructured":"14 Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141-6. doi: 10.1097\/XEB.0000000000000050","journal-title":"Int J Evid Based Healthc"},{"issue":"7","key":"key20260601162945_B15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","unstructured":"15 Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-73. doi: 10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"issue":"8","key":"key20260601162945_B16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","unstructured":"16 Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-36. doi: 10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"issue":"5","key":"key20260601162945_B17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/PGP.0000000000001000","article-title":"Evaluation of combined p57KIP2 immunohistochemistry and fluorescent in situ hybridization analysis for hydatidiform moles compared with genotyping diagnosis","volume":"43","author":"Usui","year":"2024","unstructured":"17 Usui H, Hoshimoto K, Sato A, Kano M, Fukusato T, Nakatani Y, et al. Evaluation of combined p57KIP2 immunohistochemistry and fluorescent in situ hybridization analysis for hydatidiform moles compared with genotyping diagnosis. Int J Gynecol Pathol. 2024;43(5):474-86. doi: 10.1097\/PGP.0000000000001000","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"key20260601162945_B18","first-page":"522","article-title":"Comparison of p57, c-ERBB-2, CD 117, and Bcl-2 expression in the differential diagnosis of hydatidiform mole and hydropic abortion","volume":"37","author":"Erol","year":"2016","unstructured":"18 Erol O, Suren D, Tutus B, Yararbas K, Sayiner A, Orel MK, et al. Comparison of p57, c-ERBB-2, CD 117, and Bcl-2 expression in the differential diagnosis of hydatidiform mole and hydropic abortion. Eur J Gynaecol Oncol. 2016;37(4):522-9. doi: 10.12892\/ejgo3139.2016","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"key20260601162945_B19","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.7314\/APJCP.2016.17.4.2061","article-title":"Role of P57KIP2 immunohistochemical expression in histological diagnosis of hydatidiform moles","volume":"17","author":"Triratanachat","year":"2016","unstructured":"19 Triratanachat S, Nakaporntham P, Tantbirojn P, Shuangshoti S, Lertkhachonsuk R. Role of P57KIP2 immunohistochemical expression in histological diagnosis of hydatidiform moles. Asian Pac J Cancer Prev. 2016;17(4):2061-6. doi: 10.7314\/APJCP.2016.17.4.2061","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"key20260601162945_B20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/ijmr.IJMR_982_15","article-title":"Utility of p57 immunohistochemistry in differentiating between complete mole, partial mole and non-molar or hydropic abortus","volume":"145","author":"Samadder","year":"2017","unstructured":"20 Samadder A, Kar R. Utility of p57 immunohistochemistry in differentiating between complete mole, partial mole and non-molar or hydropic abortus. Indian J Med Res. 2017;145(1):133-7. doi: 10.4103\/ijmr.IJMR_982_15","journal-title":"Indian J Med Res"},{"key":"key20260601162945_B21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.placenta.2020.07.027","article-title":"HER2 FISH and P57KIP2 immunohistochemistry using tissue microarray: improving histopathological subtyping of hydatidiform mole","volume":"99","author":"L\u00f3pez","year":"2020","unstructured":"21 L\u00f3pez CL, Figueira Gouv\u00eaa AL, Rodrigues FR, Braga A, Valente Machado MD, Lopes VS. HER2 FISH and P57KIP2 immunohistochemistry using tissue microarray: improving histopathological subtyping of hydatidiform mole. Placenta. 2020;99:166-72. doi: 10.1016\/j.placenta.2020.07.027","journal-title":"Placenta"},{"issue":"4","key":"key20260601162945_B22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/npmj.npmj_231_20","article-title":"P57kip2 immunohistochemical marker as a diagnostic tool for cases of hydatidiform moles in a tertiary health facility in Southwestern Nigeria","volume":"27","author":"Awosusi","year":"2020","unstructured":"22 Awosusi BL, Ajani MA, Adegoke OO, Salami AA, Okolo CA. P57kip2 immunohistochemical marker as a diagnostic tool for cases of hydatidiform moles in a tertiary health facility in Southwestern Nigeria. Niger Postgrad Med J. 2020;27(4):331-5. doi: 10.4103\/npmj.npmj_231_20","journal-title":"Niger Postgrad Med J"},{"issue":"5","key":"key20260601162945_B23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41379-020-00691-9","article-title":"Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases","volume":"34","author":"Xing","year":"2021","unstructured":"23 Xing D, Adams E, Huang J, Ronnett BM. Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases. Mod Pathol. 2021;34(5):961-82. doi: 10.1038\/s41379-020-00691-9","journal-title":"Mod Pathol"},{"issue":"3","key":"key20260601162945_B24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/hmbci-2020-0086","article-title":"Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes","volume":"42","author":"Zainal","year":"2021","unstructured":"24 Zainal N, Kampan NC, Rose IM, Ghazali R, Shafiee MN, Yussoff NH, et al. Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes. Horm Mol Biol Clin Investig. 2021;42(3):311-6. doi: 10.1515\/hmbci-2020-0086","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"3","key":"key20260601162945_B25","first-page":"341","article-title":"Diagnostic utility of p57 immunohistochemistry and DNA ploidy analysis by fluorescence in situ hybridisation in hydatidiform moles","volume":"43","author":"Wong","year":"2021","unstructured":"25 Wong PY, Chia WK, Selimin A, Chia PY, Mustangin M, Shuib S, et al. Diagnostic utility of p57 immunohistochemistry and DNA ploidy analysis by fluorescence in situ hybridisation in hydatidiform moles. Malays J Pathol. 2021;43(3):341-51.","journal-title":"Malays J Pathol"},{"issue":"11","key":"key20260601162945_B26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jogc.2017.05.023","article-title":"Molecular diagnosis of placental hydatidiform mole: innovation and outcomes","volume":"39","author":"Colgan","year":"2017","unstructured":"26 Colgan TJ, Noor A, Nanji S, Chang MC, Kolomietz E. Molecular diagnosis of placental hydatidiform mole: innovation and outcomes. J Obstet Gynaecol Can. 2017;39(11):1049-52. doi: 10.1016\/j.jogc.2017.05.023","journal-title":"J Obstet Gynaecol Can"},{"key":"key20260601162945_B27","doi-asserted-by":"crossref","first-page":"154041","DOI":"10.1016\/j.prp.2022.154041","article-title":"Complementary tool in diagnosis of hydatidiform mole: review","volume":"237","author":"Laviola","year":"2022","unstructured":"27 Laviola GM, Fortini AS, Salles D, Louren\u00e7o CS, Ribeiro DA, Sun SY, et al. Complementary tool in diagnosis of hydatidiform mole: review. Pathol Res Pract. 2022;237:154041. doi: 10.1016\/j.prp.2022.154041","journal-title":"Pathol Res Pract"},{"issue":"18","key":"key20260601162945_B28","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1200\/JCO-24-02326","article-title":"Practical guidelines for the treatment of gestational trophoblastic disease: collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD), European Society of Gynaecologic Oncology (ESGO), Gynecologic Cancer InterGroup (GCIG) and International Society for the Study of Trophoblastic Diseases (ISSTD)","volume":"43","author":"Lok","year":"2025","unstructured":"28 Lok C, van Trommel N, Braicu EI, Planchamp F, Berkowitz R, Seckl M, et al. Practical guidelines for the treatment of gestational trophoblastic disease: collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD), European Society of Gynaecologic Oncology (ESGO), Gynecologic Cancer InterGroup (GCIG) and International Society for the Study of Trophoblastic Diseases (ISSTD). J Clin Oncol. 2025;43(18):2119-28. doi: 10.1200\/JCO-24-02326","journal-title":"J Clin Oncol"},{"issue":"4","key":"key20260601162945_B29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-0042-1742681","article-title":"Emotional and clinical aspects observed in women with gestational trophoblastic disease: a multidisciplinary action","volume":"44","author":"Fran\u00e7a","year":"2022","unstructured":"29 Fran\u00e7a AC, Uberti EM, Muller KP, Cardoso RB, Giguer F, El Beitune P, et al. Emotional and clinical aspects observed in women with gestational trophoblastic disease: a multidisciplinary action. Rev Bras Ginecol Obstet. 2022;44(4):343-51. doi: 10.1055\/s-0042-1742681","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"6","key":"key20260601162945_B30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/REP-20-0638","article-title":"Appropriate expression of P57kip2 drives trophoblast fusion via cell cycle arrest","volume":"161","author":"Song","year":"2021","unstructured":"30 Song HL, Liu TH, Wang YH, Li FF, Ruan LL, Adu-Gyamfi, et al. Appropriate expression of P57kip2 drives trophoblast fusion via cell cycle arrest. Reproduction. 2021;161(6):633-44. doi: 10.1530\/REP-20-0638","journal-title":"Reproduction"},{"issue":"3","key":"key20260601162945_B31","first-page":"31","article-title":"The role of immunohistochemical markers in evaluating the malignant potential of molar pregnancies","volume":"13","author":"Suganthi","year":"2024","unstructured":"31 Suganthi C, Suganya U, Manibarathi R. The role of immunohistochemical markers in evaluating the malignant potential of molar pregnancies. Int J Life Sci. 2024;13(3):31-6.","journal-title":"Int J Life Sci"},{"issue":"6","key":"key20260601162945_B32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.hoc.2024.07.004","article-title":"Genetics and genomics of gestational trophoblastic disease","volume":"38","author":"Slim","year":"2024","unstructured":"32 Slim R. Genetics and genomics of gestational trophoblastic disease. Hematol Oncol Clin North Am. 2024;38(6):1219-32. doi: 10.1016\/j.hoc.2024.07.004","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:30:00Z","timestamp":1780331400000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/insights-about-use-of-p57-in-differentiation-between-complete-and-partial-hydatidiform-mole-a-scoping-review\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":32,"alternative-id":["10.61622\/rbgo\/2026rbgo16"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2026rbgo16","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e-rbgo16"}}